These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 10492360)

  • 1. Evaluation of intraoperative radiation therapy for unresectable pancreatic cancer with FDG PET.
    Higashi T; Sakahara H; Torizuka T; Nakamoto Y; Kanamori S; Hiraoka M; Imamura M; Nishimura Y; Tamaki N; Konishi J
    J Nucl Med; 1999 Sep; 40(9):1424-33. PubMed ID: 10492360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of positron emission tomography with 2-deoxy-2-[18F]fluoro-D-glucose in evaluating the effects of arterial infusion chemotherapy and radiotherapy on pancreatic cancer.
    Yoshioka M; Sato T; Furuya T; Shibata S; Andoh H; Asanuma Y; Hatazawa J; Shimosegawa E; Koyama K; Yamamoto Y
    J Gastroenterol; 2004 Jan; 39(1):50-5. PubMed ID: 14767734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal interpretation of FDG PET in the diagnosis, staging and management of pancreatic carcinoma.
    Delbeke D; Rose DM; Chapman WC; Pinson CW; Wright JK; Beauchamp RD; Shyr Y; Leach SD
    J Nucl Med; 1999 Nov; 40(11):1784-91. PubMed ID: 10565771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor response and patterns of failure following intraoperative radiotherapy for unresectable pancreatic cancer--evaluation by computed tomography.
    Kanamori S; Nishimura Y; Kokubo M; Sasai K; Hiraoka M; Shibamoto Y; Hosotani R; Imamura M; Abe M
    Acta Oncol; 1999; 38(2):215-20. PubMed ID: 10227444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical usefulness of 18-fluorodeoxyglucose positron emission tomography in the differential diagnosis, staging, and response evaluation after concurrent chemoradiotherapy for pancreatic cancer.
    Bang S; Chung HW; Park SW; Chung JB; Yun M; Lee JD; Song SY
    J Clin Gastroenterol; 2006; 40(10):923-9. PubMed ID: 17063113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of F-18-FDG PET/CT findings between pancreatic solid pseudopapillary tumor and pancreatic ductal adenocarcinoma.
    Kim YI; Kim SK; Paeng JC; Lee HY
    Eur J Radiol; 2014 Jan; 83(1):231-5. PubMed ID: 24290142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between apparent diffusion coefficients on diffusion-weighted MRI and standardized uptake value on FDG-PET/CT in pancreatic adenocarcinoma.
    Sakane M; Tatsumi M; Kim T; Hori M; Onishi H; Nakamoto A; Eguchi H; Nagano H; Wakasa K; Hatazawa J; Tomiyama N
    Acta Radiol; 2015 Sep; 56(9):1034-41. PubMed ID: 25267921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic predictive value of 18F-fluorodeoxyglucose positron emission tomography for patients with pancreatic cancer.
    Nakata B; Nishimura S; Ishikawa T; Ohira M; Nishino H; Kawabe J; Ochi H; Hirakawa K
    Int J Oncol; 2001 Jul; 19(1):53-8. PubMed ID: 11408922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing local progression after stereotactic body radiation therapy for unresectable pancreatic adenocarcinoma: CT versus PET.
    Toesca DAS; Pollom EL; Poullos PD; Flynt L; Cui Y; Quon A; von Eyben R; Koong AC; Chang DT
    Pract Radiat Oncol; 2017; 7(2):120-125. PubMed ID: 28274396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
    Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S
    Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
    Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-FDG PET is an early predictor of pathologic tumor response to preoperative radiochemotherapy in locally advanced rectal cancer.
    Cascini GL; Avallone A; Delrio P; Guida C; Tatangelo F; Marone P; Aloj L; De Martinis F; Comella P; Parisi V; Lastoria S
    J Nucl Med; 2006 Aug; 47(8):1241-8. PubMed ID: 16883000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18F-fluorodeoxyglucose positron emission tomography and the prognosis of patients with pancreatic adenocarcinoma.
    Nakata B; Chung YS; Nishimura S; Nishihara T; Sakurai Y; Sawada T; Okamura T; Kawabe J; Ochi H; Sowa M
    Cancer; 1997 Feb; 79(4):695-9. PubMed ID: 9024707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between retention index in dual-phase (18)F-FDG PET, and hexokinase-II and glucose transporter-1 expression in pancreatic cancer.
    Higashi T; Saga T; Nakamoto Y; Ishimori T; Mamede MH; Wada M; Doi R; Hosotani R; Imamura M; Konishi J
    J Nucl Med; 2002 Feb; 43(2):173-80. PubMed ID: 11850481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival after attempted surgical resection and intraoperative radiation therapy for pancreatic and periampullary adenocarcinoma.
    O'Connor JK; Sause WT; Hazard LJ; Belnap LP; Noyes RD
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1060-6. PubMed ID: 15978737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of 18F-fluorodeoxyglucose positron emission tomography imaging in surgery for pancreatic cancer.
    Wakabayashi H; Nishiyama Y; Otani T; Sano T; Yachida S; Okano K; Izuishi K; Suzuki Y
    World J Gastroenterol; 2008 Jan; 14(1):64-9. PubMed ID: 18176963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of pancreatic carcinoma: role of FDG PET.
    Keogan MT; Tyler D; Clark L; Branch MS; McDermott VG; DeLong DM; Coleman RE
    AJR Am J Roentgenol; 1998 Dec; 171(6):1565-70. PubMed ID: 9843289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of liver metastases from pancreatic cancer using FDG PET.
    Fröhlich A; Diederichs CG; Staib L; Vogel J; Beger HG; Reske SN
    J Nucl Med; 1999 Feb; 40(2):250-5. PubMed ID: 10025831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response of unresectable pancreatic cancer to intraoperative radiotherapy.
    Mariya Y; Aoki M; Anbai A; Matsukura H; Abe Y; Kimura T; Matsuda K; Ohnuma H; Yokoyama S
    Radiat Med; 1998; 16(3):195-200. PubMed ID: 9715998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does intraoperative radiation therapy improve local tumor control in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma? A propensity score analysis.
    Showalter TN; Rao AS; Rani Anne P; Rosato FE; Rosato EL; Andrel J; Hyslop T; Xu X; Berger AC
    Ann Surg Oncol; 2009 Aug; 16(8):2116-22. PubMed ID: 19437078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.